AD pathology initiates decades before the onset of gross behavioral symptoms and is primarily defined by the aggregation of β-amyloid peptide (Aβ) in extracellular plaques and of hyperphosphorylated tau proteins as intracellular neurofibrillary tangles2-4. The gene discussed is MAPT; the disease is Alzheimer disease.